SCHEMBL1721077

SCHEMBL1721077

Nc1nc(N2CCN(C(=O)COc3ccc(Br)cc3)CC2)c2nc(-c3ccc(F)cc3)sc2n1.Nc1nc(N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)c2nc(Nc3ccc(F)cc3)sc2n1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 9/20 0.62
KCNH2 Q12809 4/20 0.48
CYP3A4 P08684 2/20 0.44
CHIA Q9BZP6 1/20 0.42
ADORA2A P29274 3/20 0.39
ADORA3 P0DMS8 2/20 0.39
PPARG P37231 1/20 0.38
NR2E3 Q9Y5X4 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
POLB P06746 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.38
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654677 0.92 PI4KB (0.64) PI4KBKCNH2CYP3A4ADORA2AADORA3
SCHEMBL654372 0.89 PI4KB (0.64) PI4KBKCNH2CYP3A4CHIAPPARG
SCHEMBL653167 0.89 PI4KB (0.75) PI4KBKCNH2CYP3A4POLBLMNA
SCHEMBL656541 0.85 PI4KB (0.81) PI4KBKCNH2CYP3A4CHIAPOLB
SCHEMBL655537 0.85 PI4KB (0.68) PI4KBKCNH2CYP3A4CHIALMNA
SCHEMBL1720392 0.84 PI4KB (0.58) PI4KBKCNH2CYP3A4CHIAPPARG
SCHEMBL654457 0.82 PI4KB (0.77) PI4KBKCNH2CYP3A4POLBLMNA
SCHEMBL652821 0.82 PI4KB (0.64) PI4KBKCNH2CYP3A4LMNAMAPK1
SCHEMBL654471 0.82 PI4KB (0.75) PI4KBKCNH2CYP3A4POLBLMNA
SCHEMBL652412 0.82 PI4KB (0.65) PI4KBKCNH2CYP3A4POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2405973-A2 THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2012-01-18 EP disclosed